TD Cowen Upgrades Pembina Pipeline to Buy From Hold, Adjusts PT to CA$75 From CA$65

JPMorgan Initiates Seaport Therapeutics at Overweight With $42 Price Target

UBS Upgrades Vipshop to Buy From Neutral, Adjusts PT to $18.50 From $20

Vipshop Holdings Ltd (VIPS) has an average rating of overweight and mean price target of $18.90, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Jefferies & Co Initiates Coverage on Hemab Therapeutics With Buy Rating, $39 Price Target

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)